MAPT and early-onset autosomal dominant Alzheimer disease: Several adrenergic receptors, including α or β adrenergic receptors, have been studied in Alzheimer’s disease mice models, where their blockade or activation has been shown to affect cognitive functions and the processing and secretion of Aβ and tau pathology [30].